GRAIL, Inc. - Common Stock (GRAL)
43.03
-7.18 (-14.30%)
NASDAQ · Last Trade: Feb 24th, 1:25 AM EST
NEW YORK, NY - February 23, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
Via TheNewswire.com · February 23, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 23, 2026
Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Grail, Inc. (NASDAQ: GRAL). The investigation focuses on Grail’s executive officers and whether investor losses may be recovered under federal securities laws.
By Johnson Fistel, PLLP · Via Business Wire · February 19, 2026

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.
Via MarketBeat · July 16, 2024